“Consider Discontinuing”: FDA Slaps “Eye Stroke” Warning On All GLP-1 Weight-Loss Drugs

The FDA is requiring the makers of every GLP-1 drug on the U.S. market, Ozempic, Wegovy, Mounjaro and Zepbound among them, to warn of a potential increased risk of an “eye stroke” that can cause sudden, permanent vision loss in one eye. The condition is non-arteritic anterior ischemic optic neuropathy, or NAION. The agency’s Nov. 9 drug safety communication puts…